Treatment outcome of docetaxel, capecitabine and cisplatin regimen for patients with refractory and relapsed nasopharyngeal carcinoma who failed previous platinum-based chemotherapy

Organ preservation using carboplatin, capecitabine, docetaxel, and radiotherapy in head and neck cancer: A phase II study.

(2017) D. F. Saragiotto et al.   JOURNAL OF CLINICAL ONCOLOGY

Multicenter phase II study of capecitabine combined with nedaplatin for recurrent and metastatic nasopharyngeal carcinoma patients after failure of cisplatin-based chemotherapy

(2013) Pei-Jian Peng et al.   CANCER CHEMOTHERAPY AND PHARMACOLOGY

Open-label, single-arm phase II study of pemetrexed in the treatment of patients with recurrent or metastatic nasopharyngeal carcinoma who have had prior platinum-based chemotherapy

(2012) Yang Zhang et al.   CANCER CHEMOTHERAPY AND PHARMACOLOGY

Salvage gemcitabine–vinorelbine chemotherapy in patients with metastatic nasopharyngeal carcinoma pretreated with platinum-based chemotherapy

(2012) Cui Chen et al.   ORAL ONCOLOGY

Plasma Epstein-Barr virus DNA level strongly predicts survival in metastatic/recurrent nasopharyngeal carcinoma treated with palliative chemotherapy

(2011) Xin An et al.   CANCER

Long-term Outcomes and Prognostic Factors of Re-irradiation for Locally Recurrent Nasopharyngeal Carcinoma using Intensity-modulated Radiotherapy

(2011) Fei Han et al.   CLINICAL ONCOLOGY

Docetaxel is effective in heavily pretreated patients with disseminated nasopharyngeal carcinoma

(2010) J. Ngeow et al.   ANNALS OF ONCOLOGY

Phase I/II study of a combination of docetaxel, capecitabine, and cisplatin (DXP) as first-line chemotherapy in patients with advanced gastric cancer

(2010) Yoon-Koo Kang et al.   CANCER CHEMOTHERAPY AND PHARMACOLOGY

Phase II study of docetaxel, capecitabine, and cisplatin as neoadjuvant chemotherapy for locally advanced breast cancer

(2010) Yen-Shen Lu et al.   CANCER CHEMOTHERAPY AND PHARMACOLOGY

Plasma EBV DNA Clearance Rate as a Novel Prognostic Marker for Metastatic/Recurrent Nasopharyngeal Carcinoma

(2010) W.-Y. Wang et al.   CLINICAL CANCER RESEARCH

Triplet combination of gemcitabine, paclitaxel, and carboplatin followed by maintenance 5-fluorouracil and folinic acid in patients with metastatic nasopharyngeal carcinoma

(2008) Swan Swan Leong et al.   CANCER

Phase II study of capecitabine and cisplatin combination as first-line chemotherapy in Chinese patients with metastatic nasopharyngeal carcinoma

(2008) Yu-Hong Li et al.   CANCER CHEMOTHERAPY AND PHARMACOLOGY

Phase II study of gefitinib for the treatment of recurrent and metastatic nasopharyngeal carcinoma

(2008) Daniel T. T. Chua et al.   HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK

Capecitabine Monotherapy for Recurrent and Metastatic Nasopharyngeal Cancer

(2008) D. Chua et al.   JAPANESE JOURNAL OF CLINICAL ONCOLOGY

Transcriptional patterns, biomarkers and pathways characterizing nasopharyngeal carcinoma of Southern China

(2008) Weiyi Fang et al.   Journal of Translational Medicine